A network-based biomarker approach for molecular investigation and diagnosis of lung cancer
2011

Network-based Biomarker for Lung Cancer Diagnosis

Sample size: 187 publication Evidence: moderate

Author Information

Author(s): Wang Yu-Chao, Chen Bor-Sen

Primary Institution: National Tsing Hua University

Hypothesis

There is no highly sensitive network-based method for carcinogenesis characterization and diagnosis from the systems perspective.

Conclusion

The network-based biomarker is effective in diagnosing smokers with signs of lung cancer and highlights potential therapeutic targets.

Supporting Evidence

  • 40 significant proteins in lung carcinogenesis were identified.
  • The network-based biomarker proved effective in diagnosing smokers with signs of lung cancer.
  • The method showed a sensitivity of 83.33% and a specificity of 64.71%.

Takeaway

Researchers created a new way to find out if smokers have lung cancer by looking at how proteins in their bodies interact with each other.

Methodology

The study integrated microarray gene expression profiles and protein-protein interaction information to develop a network-based biomarker.

Potential Biases

The method may misclassify smokers without cancer as having cancer due to similarities in molecular patterns.

Limitations

The study's sample size limited the number of proteins included in the network-based biomarker, potentially excluding relevant proteins.

Participant Demographics

The study included 79 smokers with lung cancer and 73 smokers without lung cancer in the primary data set.

Statistical Information

P-Value

< 1e-5

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/1755-8794-4-2

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication